A brand-name drug that is relabeled and marketed under a generic product name is an:

A brand-name drug that is relabeled and marketed under a generic product name is referred to as an authorized generic. This occurs when a pharmaceutical company produces a generic version of its own branded medication and sells it under its chemical name without the brand label, often at a lower price. The key aspect distinguishing authorized generics from other types of generics is that they are manufactured by the same company that produced the original brand-name drug, ensuring that they have the same formulation, dosage, and quality as the brand-name medication.

Unlike standard generics, which are produced by different companies and may utilize different manufacturing processes, an authorized generic is essentially the original brand-name drug sold under a different name. This allows consumers to access medications at potentially reduced costs while still expecting the same therapeutic effects and standards of quality as the original product. The classification of an authorized generic is important in regulatory contexts and for patients looking for cost-effective medication options while ensuring safety and efficacy.